The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, however its position within the broader industry now triggers questions about long-term gains. Alternative versions are eroding market share, prompting anxieties that betting on companies significantly dependent to Viagra's previous standing could be a s